Tirzepatide Weight Loss
in Torrance
Dual-action GLP-1 and GIP therapy. Clinically supervised, pharmacy-grade, results-focused.
Important: Tirzepatide is a prescription medication. Treatment is provided only after an in-person medical evaluation by a licensed provider who confirms clinical appropriateness. Online purchases, if any, are prepaid credits for consultation and potential treatment. If you are not a candidate, you will receive a full refund or the same credit may be applied to another eligible service.
Tirzepatide at a Glance
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the first of its kind to target two metabolic pathways simultaneously. This dual action produces stronger appetite suppression and more significant weight reduction than single-pathway treatments in clinical studies. At Skin Works, every program is physician-supervised, LegitScript certified, and sourced exclusively from FDA-registered licensed pharmacies.
What Is Tirzepatide?
Tirzepatide is a prescription medication that activates both GIP and GLP-1 receptors, the two metabolic pathways involved in appetite regulation, insulin sensitivity, and energy balance. Targeting both at once is what distinguishes it from single-pathway GLP-1 medications.
Dual-Receptor Mechanism
By activating GIP alongside GLP-1, tirzepatide produces stronger appetite suppression and more consistent blood sugar support than GLP-1-only medications for many patients.
Personalized Dosing
Your provider titrates your dose gradually, starting low and advancing only once you’ve built tolerance. No two patients follow an identical schedule.
Physician-Supervised, Pharmacy-Grade
Medication is sourced exclusively from FDA-registered, licensed pharmacies through a LegitScript certified practice. Every dose change is reviewed by a licensed provider.
A provider consultation reviews medical history, goals, dosing, and whether tirzepatide is clinically appropriate.
Who Tirzepatide Is Best For
This page is educational. An in-person medical evaluation is required to confirm candidacy and build a safe, appropriate plan.
- Adults seeking a medically supervised approach to weight loss
- Patients who have not reached their goals through diet and exercise alone
- Patients comfortable with weekly injections and ongoing provider check-ins
- No personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Not pregnant, planning pregnancy, or breastfeeding
What We Evaluate Before Prescribing
Full medical history, current medications, and prior weight-loss attempts
Contraindications, including thyroid and pancreatic history
Prior experience with GLP-1 or GIP medications, if any
Realistic goals, timeline, and appropriate starting dose
Whether in-clinic dosing or an eventual take-home protocol fits your schedule
Whether a different medical weight-loss approach may be a better fit for you
Find Your Starting Point
Answer four short questions and we’ll point you to the right next step.
What’s your main goal?
How soon are you looking to start?
Have you used a GLP-1 or GIP medication before?
Do you prefer to book or text first?
Thanks! Based on your answers, here’s the best next step:
Book Your Free ConsultationHow Tirzepatide Works
Dual Mechanism
Activates both GIP and GLP-1 receptors, the first medication of its kind to target two metabolic pathways at once.
Appetite Suppression
Slows gastric emptying and reduces hunger signals, producing stronger appetite control than single-pathway medications for many patients.
Blood Sugar Support
Improves insulin sensitivity and glucose regulation, with added benefit from the GIP pathway.
Gradual Body Composition Change
Clinical studies show patients achieving up to 22% body weight reduction over 3 to 6 months with continued provider oversight.
Tirzepatide vs. Semaglutide
Both are effective GLP-1 medications. Your provider will recommend the right option after your evaluation.
Mechanism and Appetite Suppression
Semaglutide targets the GLP-1 pathway alone, with strong appetite suppression for most patients. Tirzepatide adds a second GIP pathway, which produces stronger appetite suppression for many patients and is associated with up to 22% weight loss in clinical trials, compared to up to 15% for semaglutide.
Blood Sugar Support and Take-Home Dosing
Both medications support healthy blood sugar levels, with tirzepatide offering an added benefit from its GIP action. Both also offer a take-home dosing option once your provider clears you to self-administer, using the same medication, pharmacy, and price as in-clinic dosing.
Pricing
Semaglutide starts at $370 per month and tirzepatide starts at $380 per month. The small difference in starting price reflects the dual-action formulation, not a difference in the level of provider care.
Not sure whether tirzepatide or semaglutide is the better fit? Text us a question and we’ll help you decide.
Text Us a QuestionHow the Program Works
Free Consultation
Meet with a licensed provider in clinic. We review your health history, discuss your goals, and determine if tirzepatide is appropriate for you. No pressure, no commitment.
Medical Evaluation and Prescription
If you are a good candidate, your provider writes a prescription and explains your starting dose, what to expect, and how to manage any side effects.
Dosing, In-Clinic or Take-Home
Most patients start in clinic with full provider oversight. Once established on your protocol, your provider may clear you to administer doses at home with supplied syringes and instructions. Same medication, same pharmacy, same price.
Ongoing Progress Reviews
We track your results with check-ins, photos, and measurements. Your plan evolves with you, not a one-size-fits-all protocol.
Typical Results Timeline
Titration Begins
Dosing starts at the lowest level to build tolerance. Many patients notice reduced appetite within the first two weeks. Your provider reviews nutrition and hydration to support your early progress.
Dose Adjustment
Dose may be adjusted based on your individual response. The dual-action mechanism typically produces more consistent appetite control than single-pathway medications at this stage.
Visible Body Composition Change
Noticeable changes often become visible. Clinical studies show tirzepatide patients achieving up to 22% body weight reduction over this period with continued provider oversight.
Long-Term Stability
Your provider helps you stabilize at a sustainable long-term plan. Regular check-ins continue to support consistency and address any plateaus as they arise.
Medication preparation is handled with clinical oversight, clear dosing instructions, and provider review at each stage.
What Is Included in Your Program
Medical Evaluation and Eligibility Screening
In-clinic assessment by a licensed provider before any prescription is written.
Personalized Dose Titration
Your provider adjusts your dose based on how your body responds. Not a standard protocol.
In-Clinic Dosing or Take-Home Option
Start in clinic with full oversight. Once established, your provider may clear you to take syringes and supplies home. Same medication, same pharmacy, same price.
Pharmaceutical-Grade Medication From Licensed Sources
We source exclusively from FDA-registered, licensed pharmacies. LegitScript certified practice. No gray-market compounds.
Side Effect Support
Nausea, hydration, and comfort protocols managed in clinic, not through a chat window.
Nutrition and Habit Guidance
Practical advice aligned with your schedule and lifestyle, not generic handouts.
Progress Reviews
Photos, measurements, and plan adjustments so your program evolves as you do.
Program Fees
All packages include doses based on your provider-approved protocol. First-time patients save $100 on any package. Actual dosing determined at consultation. Tap any treatment below to see full details and package pricing.
Frequently Asked Questions
How is tirzepatide different from semaglutide?
Tirzepatide targets two receptors, GLP-1 and GIP, while semaglutide targets only GLP-1. This dual mechanism may support stronger appetite regulation and greater weight reduction for some patients. Your provider will recommend the right option based on your health profile.
Is tirzepatide FDA approved for weight loss?
Tirzepatide is FDA approved under Zepbound for chronic weight management and under Mounjaro for type 2 diabetes. Your provider will determine the appropriate formulation for your situation during your consultation.
What results can I expect?
Results vary based on medical history, dose, consistency, nutrition, activity, and follow-up. Your provider will help set realistic expectations and adjust your plan as your body responds.
How often do I need to come in?
Most patients begin with regular in-clinic visits for dose administration and monitoring. Once established on your protocol, your provider may clear you to administer doses at home with supplied syringes and instructions at no additional cost.
Is tirzepatide safe?
Side effects are typically gastrointestinal and may be more noticeable during dose changes. Your provider reviews your full medical history before prescribing. All treatment decisions are made by a licensed clinician after an in-person evaluation.
Can I switch from semaglutide to tirzepatide?
Some patients may be candidates to transition. Your provider will evaluate your history, current dose, tolerance, goals, and contraindications before recommending a safe starting point.
Does the New Patient Rate apply to every visit?
No. The New Patient Rate is calculated independently from the standard rate and applies to your first visit only. Ongoing months are billed at the standard package rate shown above.
Tirzepatide Weight Loss in Torrance and the South Bay
Visit us at 2573 Pacific Coast Highway, Suite B in Rolling Hills Plaza, Torrance. Easy freeway access and free parking on site. Mon to Fri: 10:00 AM to 6:00 PM · Sat: 10:00 AM to 5:00 PM. We regularly see patients from Redondo Beach, Manhattan Beach, Hermosa Beach, Palos Verdes, Gardena, Carson, Lomita, and San Pedro.
|
Complimentary Consultations Available
Ready to Explore Your Options?
Your free consultation is a private conversation with a licensed clinician. No commitment required.
|
Medical Disclaimer: Tirzepatide is a prescription medication. Treatment is provided only after an in-person medical evaluation confirming clinical appropriateness. This page is for informational purposes only and does not constitute medical advice. Individual results vary.
Medication: Tirzepatide is FDA approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Off-label use for weight management requires provider evaluation. Medication is not dispensed or sold online by Skin Works. All services are delivered on site after medical clearance.
Pricing: New Patient Rate is calculated independently from the standard rate, applies to your first visit only, and cannot be combined with any other offer.
Financing: Payment plans are provided by third-party lenders and subject to their approval processes and terms.
Skin Works Medical Spa, Rolling Hills Plaza, 2573 Pacific Coast Highway, Suite B, Torrance, CA 90505, (844) 759-6757